Posted inHealth News Policy News Regulatory News
FDA Panel Calls for Reclassification of Testosterone, Expanding Access for Men with Low Hormone Levels
Posted by
No Comments
No Comments
On Wednesday, a 13‑member FDA panel urged the agency to strip testosterone of its controlled‑substance status and broaden labeling, a move that could...